NEWSLETTER

Sign up to read weekly email newsletter

13 years 🥳 of Publication, 100k+ Stories, 30+ Countries

Legal Desire Media and Insights
Donate
Search
  • Law Firm & In-house Updates
  • Deals
  • Interviews
  • Insight
  • Read to know
  • Courses
Reading: Ropes & Gray Advises LianBio in Agreement with Bristol Myers Squibb for Heart Drug Rights in Asia
Share
Aa
Legal Desire Media and InsightsLegal Desire Media and Insights
  • Law Firm & In-house Updates
  • Deals
  • Interviews
  • Insight
  • Read to know
  • Courses
Search
  • Law Firm & In-house Updates
  • Deals
  • Interviews
  • Insight
  • Read to know
  • Courses
Follow US
Legal Desire Media & Insights
Home » Blog » Ropes & Gray Advises LianBio in Agreement with Bristol Myers Squibb for Heart Drug Rights in Asia
Deals

Ropes & Gray Advises LianBio in Agreement with Bristol Myers Squibb for Heart Drug Rights in Asia

By Legal Desire 2 Min Read
Share
www.ropesgray.com. (PRNewsFoto/Ropes & Gray LLP)

Ropes & Gray represented LianBio in an agreement with Bristol Myers Squibb where BMS has obtained LianBio’s exclusive rights to develop and commercialize heart drug mavacamten, in mainland China, Hong Kong, Macau, Taiwan, Singapore and Thailand, in conjunction with termination of the exclusive license agreement LianBio previously entered into with MyoKardia, Inc., now a wholly owned subsidiary of BMS, in August 2020 to acquire these rights. The agreement was announced on October 24.

Under the agreement, LianBio will receive a $350 million one-time payment. In addition, LianBio will be released from payment obligations of up to $127.5 million in remaining milestone payments under the MyoKardia license agreement.

Mavacamten is approved in the U.S. as Camzyos to treat symptomatic obstructive hypertrophic cardiomyopathy, a condition that can affect the function of the heart by blocking or reducing blood flow to the rest of the body. In April 2023, the China National Medical Products Administration accepted with Priority Review a New Drug Application for mavacamten for treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy.

The Ropes & Gray LianBio team was led by life sciences partners Eric Wu and Hannah England and capital markets partner Zach Blume and included capital markets partner Tom Danielski, life sciences partner Katherine Wang, IP transactions partner Melissa Rones, tax partner David Saltzman, employment & benefits partner Renata Ferrari, litigation & enforcement partner Rocky Tsai, and employment & benefits principle Christine Joyce.

You Might Also Like

Dentons Link Legal advises Genesys International on its Qualified Institutions Placement

Dentons Link Legal Advises Tata Capital on Financing of Cleantech Solar

Freshfields advises Sun King Nigeria on c.$80m local currency financing

Freshfields advises Charterhouse on the entry of new investors in Novétude

Mayer Brown advises Vitruvian Partners on acquisition of premium travel business Great Rail Journeys

Subscribe

Subscribe to our newsletter to get our newest articles instantly!

Don’t miss out on new posts, Subscribe to newsletter Get our latest posts and announcements in your inbox.

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.

Don’t miss out on new posts, Subscribe to newsletter Get our latest posts and announcements in your inbox.

By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Legal Desire October 27, 2023
Share this Article
Facebook Twitter Email Copy Link Print

YOU MAY ALSO LIKE

Dentons Link Legal advises Genesys International on its Qualified Institutions Placement

Dentons Link Legal acted as the sole legal counsel as to Indian laws for the qualified institutions placement of equity…

Deals
May 27, 2025

Dentons Link Legal Advises Tata Capital on Financing of Cleantech Solar

Dentons Link Legal acted as legal counsel to Tata Capital Limited in connection with the extension of financial assistance to…

Deals
May 27, 2025

Freshfields advises Sun King Nigeria on c.$80m local currency financing

Global law firm Freshfields has advised Greenlight Planet Sun King Nigeria (Sun King Nigeria), a leading distributor and financier of…

Deals
May 24, 2025

Freshfields advises Charterhouse on the entry of new investors in Novétude

Freshfields advised Charterhouse Capital Partners (“Charterhouse”), one of the longest-established private equity firms operating in Europe, on the transaction involving…

Deals
May 19, 2025

For over 10 years, Legal Desire provides credible legal industry updates and insights across the globe.

  • About
  • Contact Us
  • Legal Marketing Service for Law Firms and Lawyers
  • Privacy Policy
  • Terms & Condition
  • Cancellation/Refund Policy

Follow US: 

Legal Desire Media & Insights

For Submissions/feedbacks/sponsorships/advertisement/syndication: office@legaldesire.com

Legal Desire Media & Insights 2023

✖
Cleantalk Pixel

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?